Literature DB >> 2042747

Abnormalities in premigratory granule cells in the weaver cerebellum defined by monoclonal antibody OZ42.

R J Smeyne1, L B Pickford, R V Rouse, J Napieralski, D Goldowitz.   

Abstract

The immunoreactivity in OZ42, a neural cell specific antibody that recognizes premigratory cerebellar granule cells, was examined in early postnatal wild-type and weaver mouse cerebella. We find that the OZ42-positive staining in the external granular layer (EGL) is first seen at postnatal day 1 in the most posterior and ventral aspect of midline cerebellum in the wild-type and heterozygous weaver mouse. By postnatal day 4 strong immunoreactivity is observed in the EGL of all cerebellar lobules. This staining is localized to a band of immunoreactive cells present at the interface of the EGL and the molecular layer (ML). In the homozygous weaver cerebellum, OZ42-positive staining is not seen until postnatal day 3. In the postnatal day 4 weaver cerebellum, immunoreactivity is considerably ligther than in littermate control cerebella, and found throughout the width of the EGL (i.e., not localized to the EGL-ML interface). This study demonstrates that the expression of a specific marker of granule cell development is abnormal in the granule cell population of the homozygous weaver mouse, a population of cells known to be intrinsically affected by the action of this mutant gene. In the light of previous studies, which have shown that the weaver phenotype is identifiable as early as the day of birth, and that the OZ42-antigen may be involved with the development process of axonal growth, it is reasonable to suggest that the weaver mutation results in an abnormality in the ability of granule cells to produce and/or stabilize axons.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2042747     DOI: 10.1007/bf00192209

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  19 in total

1.  The weaver granuloprival phenotype is due to intrinsic action of the mutant locus in granule cells: evidence from homozygous weaver chimeras.

Authors:  D Goldowitz
Journal:  Neuron       Date:  1989-06       Impact factor: 17.173

2.  The mouse neurological mutant weaver maps within the region of chromosome 16 that is homologous to human chromosome 21.

Authors:  R H Reeves; M R Crowley; N Lorenzon; W J Pavan; R J Smeyne; D Goldowitz
Journal:  Genomics       Date:  1989-10       Impact factor: 5.736

3.  Regional differences in cytoarchitecture of the weaver cerebellum suggest a new model for weaver gene action.

Authors:  K Herrup; E Trenkner
Journal:  Neuroscience       Date:  1987-12       Impact factor: 3.590

4.  Spatial regulation of axonal glycoprotein expression on subsets of embryonic spinal neurons.

Authors:  J Dodd; S B Morton; D Karagogeos; M Yamamoto; T M Jessell
Journal:  Neuron       Date:  1988-04       Impact factor: 17.173

5.  Sequence of developmental abnormalities leading to granule cell deficit in cerebellar cortex of weaver mutant mice.

Authors:  P Rakic; R L Sidman
Journal:  J Comp Neurol       Date:  1973-11-15       Impact factor: 3.215

6.  Postnatal development of the cerebellar cortex in the rat. 3. Maturation of the components of the granular layer.

Authors:  J Altman
Journal:  J Comp Neurol       Date:  1972-08       Impact factor: 3.215

7.  Neuron-glia relationship during granule cell migration in developing cerebellar cortex. A Golgi and electronmicroscopic study in Macacus Rhesus.

Authors:  P Rakic
Journal:  J Comp Neurol       Date:  1971-03       Impact factor: 3.215

8.  Molecular approaches to the nervous system.

Authors:  R D McKay
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

9.  A selective stain for mitotic figures, particularly in the developing brain.

Authors:  F J Fraser
Journal:  Stain Technol       Date:  1982-07

10.  Transiently expressed, neural-specific molecule associated with premigratory granule cells in postnatal mouse cerebellum.

Authors:  L B Pickford; D N Mayer; L M Bolin; R V Rouse
Journal:  J Neurocytol       Date:  1989-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.